{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:42:06Z","timestamp":1787755326686,"version":"build-2784847793"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Bone and Joint Surgery"],"published-print":{"date-parts":[[2017,10,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Epsilon-aminocaproic acid (EACA) and tranexamic acid (TXA) are synthetic amino acid derivatives that interfere with fibrinolysis, promoting hemostasis by pharmacological means. Although both drugs have been shown to decrease blood loss with a minimal risk of thromboembolic adverse events following cardiac and vascular surgery, we are aware of only 1 published trial that directly compared the antifibrinolytic effects of EACA with those of TXA after total knee arthroplasty (TKA). The primary aim of this prospective, randomized, controlled trial was to determine whether TXA provides superior blood conservation following TKA compared with that provided by EACA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 194 patients scheduled to undergo a primary unilateral TKA in the same community-based hospital were prospectively randomized to receive intravenous EACA (n = 96) or TXA (n = 98). Both the patients and the operating surgeons were blinded to the treatment assignments. Primary outcome measures included transfusions, estimated blood loss, and the drop in the hemoglobin (Hgb) level. Secondary outcomes measures included the change in the serum creatinine level, postoperative complications, and length of hospital stay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Although the patients who received TXA averaged less estimated blood loss than the patients who received EACA (t\n                      <jats:sub>185<\/jats:sub>\n                      = 2.18, p = 0.031; mean difference = 144.2 mL, 95% confidence interval = 13.62 to 274.78 mL), no transfusions were required in either group. We observed no statistically significant or clinically relevant between-group differences in the change in Hgb or serum creatinine level, postoperative complications, or length of hospital stay.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Although the estimated blood loss was significantly greater in the EACA group, no transfusions were required and no significant between-group differences were observed for any other outcomes measured. We concluded that EACA may be an acceptable alternative to TXA for blood conservation following TKA, although replication of our results in noninferiority trials is necessary.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      Therapeutic\n                      <jats:underline>Level I<\/jats:underline>\n                      . See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.16.00738","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T13:37:58Z","timestamp":1507124278000},"page":"1621-1628","source":"Crossref","is-referenced-by-count":32,"title":["Blood Conservation Using Tranexamic Acid Is Not Superior to Epsilon-Aminocaproic Acid After Total Knee Arthroplasty"],"prefix":"10.2106","volume":"99","author":[{"given":"Clifford Kent","family":"Boese","sequence":"first","affiliation":[{"name":"Miller Orthopedic Specialists, Council Bluffs, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Centeno","sequence":"additional","affiliation":[{"name":"Miller Orthopedic Specialists, Council Bluffs, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan W.","family":"Walters","sequence":"additional","affiliation":[{"name":"Department of Medicine, Creighton University, Omaha, Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"3","key":"bib1-20230810","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1302\/0301-620X.78B3.0780434","article-title":"Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomized, double-blind study of 86 patients","volume":"78","author":"Benoni","year":"1996","journal-title":"J Bone Joint Surg Br."},{"key":"bib2-20230810","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/1874325001105010044","article-title":"Blood loss control with two doses of tranexamic acid in a multimodal protocol for total knee arthroplasty","volume":"5","author":"Ortega-Andreu","year":"2011","journal-title":"Open Orthop J."},{"issue":"6","key":"bib3-20230810","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5435\/JAAOS-22-06-361","article-title":"Blood management strategies for total knee arthroplasty","volume":"22","author":"Levine","year":"2014","journal-title":"J Am Acad Orthop Surg."},{"issue":"5","key":"bib4-20230810","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/bja\/ael057","article-title":"Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial","volume":"96","author":"Camarasa","year":"2006","journal-title":"Br J Anaesth."},{"issue":"12","key":"bib5-20230810","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1177\/1060028014549558","article-title":"Efficacy and safety of tranexamic acid versus \u03b5-aminocaproic acid in cardiovascular surgery","volume":"48","author":"Falana","year":"2014","journal-title":"Ann Pharmacother."},{"issue":"1","key":"bib6-20230810","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1756-0500-6-184","article-title":"Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis","volume":"6","author":"Gandhi","year":"2013","journal-title":"BMC Res Notes."},{"issue":"5","key":"bib7-20230810","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MJT.0b013e318250f85a","article-title":"The effect of tranexamic acid on hemoglobin levels during total knee arthroplasty","volume":"21","author":"Pachauri","year":"2014","journal-title":"Am J Ther."},{"issue":"5","key":"bib8-20230810","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.thromres.2008.09.015","article-title":"Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials","volume":"123","author":"Kagoma","year":"2009","journal-title":"Thromb Res."},{"issue":"9","key":"bib9-20230810","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1007\/s11999-012-2310-y","article-title":"Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients","volume":"470","author":"Maniar","year":"2012","journal-title":"Clin Orthop Relat Res."},{"issue":"7","key":"bib10-20230810","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1538-7836.2005.01457.x","article-title":"Aprotinin and epsilon aminocaproic acid are effective in reducing blood loss after primary total hip arthroplasty\u2014a prospective randomized double-blind placebo-controlled study","volume":"3","author":"Ray","year":"2005","journal-title":"J Thromb Haemost."},{"issue":"1","key":"bib11-20230810","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/SCS.0b013e3182a2e23f","article-title":"Minimizing transfusions in primary cranial vault remodeling: the role of aminocaproic acid","volume":"25","author":"Oppenheimer","year":"2014","journal-title":"J Craniofac Surg."},{"issue":"1","key":"bib12-20230810","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.jvca.2010.10.007","article-title":"Seizures after open heart surgery: comparison of \u03b5-aminocaproic acid and tranexamic acid","volume":"25","author":"Martin","year":"2011","journal-title":"J Cardiothorac Vasc Anesth."},{"issue":"3","key":"bib13-20230810","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2165\/00003495-198529030-00003","article-title":"Clinical application of inhibitors of fibrinolysis","volume":"29","author":"Verstraete","year":"1985","journal-title":"Drugs."},{"issue":"2","key":"bib15-20230810","first-page":"224","article-title":"Prediction of blood volume in normal human adults","volume":"51","author":"Nadler","year":"1962","journal-title":"Surgery."},{"issue":"10","key":"bib16-20230810","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1046\/j.1537-2995.1997.371098016448.x","article-title":"A standardized method for calculating blood loss","volume":"37","author":"Brecher","year":"1997","journal-title":"Transfusion."},{"issue":"3","key":"bib17-20230810","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2307\/2336502","article-title":"Discrete sequential boundaries for clinical trials","volume":"70","author":"Lan","year":"1983","journal-title":"Biometrika."},{"issue":"13-14","key":"bib18-20230810","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/sim.4780131308","article-title":"Interim analysis: the alpha spending function approach","volume":"13","author":"DeMets","year":"1994","journal-title":"Stat Med."},{"issue":"2","key":"bib19-20230810","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/biomet\/64.2.191","article-title":"Group sequential methods in the design and analysis of clinical trials","volume":"64","author":"Pocock","year":"1977","journal-title":"Biometrika."},{"issue":"1","key":"bib20-20230810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12630-011-9621-4","article-title":"\u201cSeizing\u201d the opportunity to understand antifibrinolytic drugs","volume":"59","author":"Lecker","year":"2012","journal-title":"Can J Anaesth."},{"key":"bib21-20230810","first-page":"1CD001886","article-title":"Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion","author":"Henry","year":"2011","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"bib22-20230810","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5435\/00124635-201003000-00002","article-title":"Antifibrinolytics in major orthopaedic surgery","volume":"18","author":"Eubanks","year":"2010","journal-title":"J Am Acad Orthop Surg."},{"issue":"2","key":"bib23-20230810","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1503\/cmaj.081109","article-title":"The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis","volume":"180","author":"Henry","year":"2009","journal-title":"CMAJ."},{"issue":"6","key":"bib24-20230810","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1053\/j.jvca.2013.04.003","article-title":"Comparison of epsilon aminocaproic acid and tranexamic acid in thoracic aortic surgery: clinical efficacy and safety","volume":"27","author":"Makhija","year":"2013","journal-title":"J Cardiothorac Vasc Anesth."},{"issue":"2","key":"bib25-20230810","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1213\/ANE.0b013e3181c92b23","article-title":"High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients","volume":"110","author":"Murkin","year":"2010","journal-title":"Anesth Analg."},{"issue":"12","key":"bib26-20230810","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1302\/0301-620X.93B12.26989","article-title":"Tranexamic acid in total knee replacement: a systematic review and meta-analysis","volume":"93","author":"Alshryda","year":"2011","journal-title":"J Bone Joint Surg Br."},{"issue":"13","key":"bib27-20230810","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2106\/JBJS.K.00873","article-title":"Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis","volume":"94","author":"Yang","year":"2012","journal-title":"J Bone Joint Surg Am."},{"issue":"3","key":"bib28-20230810","first-page":"185","article-title":"The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: a pilot study","volume":"45","author":"Harley","year":"2002","journal-title":"Can J Surg."},{"issue":"3","key":"bib29-20230810","first-page":"341","article-title":"Topical use of antifibrinolytic agent to reduce postoperative bleeding after coronary artery bypass surgery","volume":"24","author":"Breda","year":"2009","journal-title":"Rev Bras Cir Cardiovasc."},{"issue":"6","key":"bib30-20230810","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/1076029613476338","article-title":"A randomized trial of the topical effect of antifibrinolytic epsilon aminocaproic acid on coronary artery bypass surgery without cardiopulmonary bypass","volume":"20","author":"Gurian","year":"2014","journal-title":"Clin Appl Thromb Hemost."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004623-201710040-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:41:07Z","timestamp":1787751667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004623-201710040-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,4]]},"references-count":29,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.16.00738","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,4]]}}}